Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients

NeuroReport

Volumn 11, Issue 10, 2000, Pages 2079-2082

  Wintermeyer, Philip ^a   Krüger, Rejko ^a   Kuhn, Wilfried ^a   Müller, Thomas ^a   Woitalla, Dirk ^a   Berg, Daniela ^c   Becker, Georg ^c   Leroy, Elisabeth ^b   Polymeropoulos, Mihael ^b   Berger, Klaus ^c   Przuntek, Horst ^a   Schöls, Ludger ^a   Epplen, Jörg T ^a   Riess, Olaf ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NONE

Author keywords

Autosomal dominant; Parkinson's disease; Population studies; UCHL1

Indexed keywords

OXYGENASE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; NERVE DEGENERATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034647948     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200007140-00004     Document Type: Article

References (23)

1. 1. Pollanen MS, Dickson DW and Bergeron C. J Neuropath Exp Neurol 52, 183-191 (1993).
2. 2. Spillantini MG, Schmidt ML, Lee VMY et al. Nature 388, 839-840 (1997).
3. 3. Polymeropoulos MH, Laavedan C, Leroy E et al. Science 276, 2045-2047 (1997).
4. 4. Krüger R, Kuhn W, Müller Th et al. Nature Genet 18, 106-108 (1998).
5. 5. Riess O, Jakes R and Krüger R. Mol Med Today 4, 438-444 (1998).
6. 6. Leroy E, Boyer R, Auburger G et al. Nature 395, 451-452 (1998).
7. 7. Larsen CN, Krantz BA and Wilkinson KD. Biochemistry 37, 3358-3368 (1998).
8. 8. Krüger R, Vieira-Säcker AMM, Kuhn W et al. J Neural Transm 106, 159-163 (1999).
9. 9. Hense HW, Stieber J, Filipiak B et al. Ann Epidemiol 3, 410-416 (1993).
10. 10. Fahn S, Elton R, Members of the UPDRS Development Committee. Recent developments in Parkinson's disease. In: Fahn S, Marsden CD, Calne DB and Goldstein M, eds. Macmillan Health Care Information. NJ: Florham Park; 1987, pp. 153-163.
11. 11. Raymond M and Rousset F. J Hered 86, 248-249 (1995).
12. 12. Louis EJ and Dempster ER. Biometrics 43, 800-802 (1987).
13. 13. Rousset F and Raymond M. Genetics 140, 1413-1419 (1995).
14. 14. Svejgard A and Ryder LP. Immun Rev 70, 193-218 (1982).
15. 15. Svejgard A and Ryder LP. Tissue Antigens 43, 18-27 (1994).
16. 16. Harhangi BS, Farrer MJ, Lincoln S et al. Neurosci Lett 270, 1-4 (1999).
17. 17. Lincoln S, Vaughan J, Wood N et al. Neuroreport 10, 427-429 (1999).
18. 18. Farrer M, Gwinn-Hardy K, Muenter M et al. Hum Mol Genet 8, 81-85 (1999).
19. 19. Saigoh K, Wang YL, Suh JG et al. Nat Genet 23, 47-51 (1999).
20. 20. Maraganore DM, Farrer MJ, Hardy JA et al. Neurology 53, 1858-1860 (1999).
21. 21. Comings DE. Mol Psychiatry 4, 213-215 (1999).
22. 22. Krüger R, Kuhn W, Müller T et al. Ann Neurol 45, 611-617 (1999).
23. 23. Bennett MC, Bishop JF, Leng Y et al. J Biol Chem 48, 33855-33858 (1999).